TheEdgeResearch
Home / Stocks / PLX

Protalix BioTherapeutics, Inc. (PLX)

AMEX Healthcare Biotechnology
$2.90 ▼ -5.23%
Market Cap
$244.5M
Sector
Healthcare
Industry
Biotechnology
Beta
0.01
52-Wk Range
1.65-3.19
CEO
Dror Bashan
Country
US
Currency
USD

Protalix BioTherapeutics, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Hackensack, NJ, US. The stock last traded at $2.90, down 5.23% on the session, giving a market capitalisation of $244.5M. On trailing twelve-month figures it carries a trailing P/E of 11.15, a net margin of 24.3%. Its beta of 0.01 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
11.15
Price / Sales
2.89
Price / Book
2.90
EV / EBITDA
8.11
Gross margin
71.2%
Operating margin
29.8%
Net margin
24.3%
Return on equity
—
Debt / equity
0.11
Current ratio
3.27
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
New York Stock Exchange Arca
Employees
226
IPO date
1998-05-15
Headquarters
Hackensack, NJ, US
About Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company provides Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell expressed recombinant PEGylated Uricase, which is in Phase 2 trial for the treatment of gout; and PRX-119, a plant cell expressed PEGylated recombinant human DNase I product candidate for the treatment of neutrophil extracellular traps diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. Protalix BioTherapeutics, Inc. has strategic partnership with Secarna Pharmaceuticals GmbH & Co KG. The company is headquartered in Hackensack. New Jersey.

Comparable companies

Protalix BioTherapeutics, Inc. is most often compared with the following Healthcare names:

PHARPLYXRARE
More research on PLX
PLX technical analysis PLX TheEdge Score Compare against peers
Open full interactive analysis & DCF →